213 related articles for article (PubMed ID: 27362480)
1. Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers.
Lv PC; Putt KS; Low PS
Bioconjug Chem; 2016 Jul; 27(7):1762-9. PubMed ID: 27362480
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Nonpeptidic Ligand Conjugates for the Treatment of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers.
Lv PC; Roy J; Putt KS; Low PS
Mol Cancer Ther; 2017 Mar; 16(3):453-460. PubMed ID: 27980101
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of
Nakai M; Pan J; Lin KS; Thompson JR; Nocentini A; Supuran CT; Nakabayashi Y; Storr T
J Inorg Biochem; 2018 Aug; 185():63-70. PubMed ID: 29778927
[TBL] [Abstract][Full Text] [Related]
4. Development of the
Iikuni S; Tanimura K; Watanabe H; Shimizu Y; Saji H; Ono M
Mol Pharm; 2019 Apr; 16(4):1489-1497. PubMed ID: 30892905
[TBL] [Abstract][Full Text] [Related]
5. A 99mTc-Labeled Ligand of Carbonic Anhydrase IX Selectively Targets Renal Cell Carcinoma In Vivo.
Krall N; Pretto F; Mattarella M; Müller C; Neri D
J Nucl Med; 2016 Jun; 57(6):943-9. PubMed ID: 26912427
[TBL] [Abstract][Full Text] [Related]
6. Acetazolamide-based [
More KN; Lee JY; Kim DY; Cho NC; Pyo A; Yun M; Kim HS; Kim H; Ko K; Park JH; Chang DJ
Bioorg Med Chem Lett; 2018 Mar; 28(5):915-921. PubMed ID: 29422388
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of indium-111-labeled imidazothiadiazole sulfonamide derivative for single photon emission computed tomography imaging targeting carbonic anhydrase-IX.
Iikuni S; Okada Y; Shimizu Y; Watanabe H; Ono M
Bioorg Med Chem Lett; 2020 Jul; 30(14):127255. PubMed ID: 32527556
[TBL] [Abstract][Full Text] [Related]
8. Cancer radiotheranostics targeting carbonic anhydrase-IX with
Iikuni S; Ono M; Watanabe H; Shimizu Y; Sano K; Saji H
Theranostics; 2018; 8(11):2992-3006. PubMed ID: 29896298
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of
Zhang Z; Lau J; Zhang C; Colpo N; Nocentini A; Supuran CT; Bénard F; Lin KS
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):722-730. PubMed ID: 28385087
[TBL] [Abstract][Full Text] [Related]
10. A novel
Guan SS; Wu CT; Liao TZ; Lin KL; Peng CL; Shih YH; Weng MF; Chen CT; Yeh CH; Wang YC; Liu SH
Eur J Pharm Biopharm; 2021 Nov; 168():38-52. PubMed ID: 34450241
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of specific carbonic anhydrase inhibitors effect on hypoxic cells using electrical impedance assays.
Stanica L; Gheorghiu M; Stan M; Polonschii C; David S; Bratu D; Dinischiotu A; Supuran CT; Gheorghiu E
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1079-1090. PubMed ID: 28783982
[TBL] [Abstract][Full Text] [Related]
12. PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide.
Iikuni S; Watanabe H; Shimizu Y; Nakamoto Y; Ono M
PLoS One; 2020; 15(12):e0243327. PubMed ID: 33296398
[TBL] [Abstract][Full Text] [Related]
13. Development and biological evaluation of ⁹⁹mTc-sulfonamide derivatives for in vivo visualization of CA IX as surrogate tumor hypoxia markers.
Akurathi V; Dubois L; Celen S; Lieuwes NG; Chitneni SK; Cleynhens BJ; Innocenti A; Supuran CT; Verbruggen AM; Lambin P; Bormans GM
Eur J Med Chem; 2014 Jan; 71():374-84. PubMed ID: 24378650
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and SAR of novel Re/99mTc-labeled benzenesulfonamide carbonic anhydrase IX inhibitors for molecular imaging of tumor hypoxia.
Lu G; Hillier SM; Maresca KP; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
J Med Chem; 2013 Jan; 56(2):510-20. PubMed ID: 23234246
[TBL] [Abstract][Full Text] [Related]
15. PEGylated Bis-Sulfonamide Carbonic Anhydrase Inhibitors Can Efficiently Control the Growth of Several Carbonic Anhydrase IX-Expressing Carcinomas.
Akocak S; Alam MR; Shabana AM; Sanku RK; Vullo D; Thompson H; Swenson ER; Supuran CT; Ilies MA
J Med Chem; 2016 May; 59(10):5077-88. PubMed ID: 27144971
[TBL] [Abstract][Full Text] [Related]
16. Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers.
Marks IS; Gardeen SS; Kurdziel SJ; Nicolaou ST; Woods JE; Kularatne SA; Low PS
Mol Pharm; 2018 Jun; 15(6):2289-2296. PubMed ID: 29715036
[TBL] [Abstract][Full Text] [Related]
17. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides.
Lau J; Zhang Z; Jenni S; Kuo HT; Liu Z; Vullo D; Supuran CT; Lin KS; Bénard F
Mol Pharm; 2016 Mar; 13(3):1137-46. PubMed ID: 26866675
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors.
Lv PC; Roy J; Putt KS; Low PS
Mol Pharm; 2016 May; 13(5):1618-25. PubMed ID: 27043317
[TBL] [Abstract][Full Text] [Related]
19. Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors.
Faes S; Planche A; Uldry E; Santoro T; Pythoud C; Stehle JC; Horlbeck J; Letovanec I; Riggi N; Datta D; Demartines N; Dormond O
Oncotarget; 2016 Jun; 7(24):36666-36680. PubMed ID: 27153561
[TBL] [Abstract][Full Text] [Related]
20. Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages.
Alsaab HO; Sau S; Alzhrani RM; Cheriyan VT; Polin LA; Vaishampayan U; Rishi AK; Iyer AK
Biomaterials; 2018 Nov; 183():280-294. PubMed ID: 30179778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
